ResearcherSichuan UniversityActive in the last 2 years
Qingquan Tan
Matched on ORCID iD 0000-0002-8421-3390; OpenAlex author ID A5007382936, A5159315388. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- Targeted inhibition of HK2 expression in pancreatic ductal adenocarcinoma reprogrammes the immune microenvironment by regulating CCL5-mediated CD8+ T cell infi… Co-author DOI 10.1016/j.intimp.2026.117602↗
- Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adenocarcinoma of the body and tail: a system… Co-author DOI 10.1097/js9.0000000000003927↗
- Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells. Co-author DOI 10.1097/cad.0000000000001561↗
- Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective a… Co-author DOI 10.1016/j.ejrad.2023.110952↗
- Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm12030756↗
- MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-020-1146-x↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunlu Tan · 4 shared papers, 2020–2026 · strength 0.92
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Paper Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarci… DOI 10.3390/jcm12030756↗
- Nengwen Ke · 3 shared papers, 2020–2026 · strength 0.67
- Paper Targeted inhibition of HK2 expression in pancreatic ductal adenocarcinoma reprogrammes the immune microenvironment by r… DOI 10.1016/j.intimp.2026.117602↗
- Paper Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma… DOI 10.1016/j.ejrad.2023.110952↗
- Paper MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. DOI 10.1186/s12935-020-1146-x↗
- Xu-Bao Liu · 2 shared papers, 2024–2026 · strength 0.59
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Xing Wang · 2 shared papers, 2024–2026 · strength 0.59
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Yonghua Chen · 2 shared papers, 2023–2024 · strength 0.48
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Paper Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarci… DOI 10.3390/jcm12030756↗
- Xubao Liu · 2 shared papers, 2023 · strength 0.44
- Paper Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma… DOI 10.1016/j.ejrad.2023.110952↗
- Paper Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarci… DOI 10.3390/jcm12030756↗
- Minglin Li · 1 shared paper, 2026 · strength 0.33
- Ziying Yao · 1 shared paper, 2026 · strength 0.33
- Xing Wang · 2 shared papers, 2020–2023 · strength 0.33
- Yichen Li · 1 shared paper, 2024 · strength 0.26
- Haoqi Zhang · 1 shared paper, 2023 · strength 0.22
- Ziyao Wang · 1 shared paper, 2023 · strength 0.22
- Guanhua Chen · 1 shared paper, 2023 · strength 0.22
- Xu-Bao Liu · 1 shared paper, 2020 · strength 0.11
- Yuqiang Shan · 1 shared paper, 2020 · strength 0.11
- Hao Zhang · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.